Ergoteles LLC Penumbra Inc Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $1.16 Million - $1.47 Million	4,277 Added 53.54%	12,265 $4.22 Million
Q1 2023 May 10, 2023	SELL	$220.43 - $278.69 $992,596 - $1.25 Million	-4,503 Reduced 36.05%	7,988 $2.23 Million
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $1.9 Million - $2.85 Million	12,491 New	12,491 $2.78 Million
Q2 2022 Aug 12, 2022	BUY	$116.09 - $227.33 $1.53 Million - $2.99 Million	13,174 New	13,174 $1.64 Million
Q3 2021 Nov 15, 2021	SELL	$250.72 - $291.24 $2.48 Million - $2.88 Million	-9,902 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$235.0 - $310.7 $2.33 Million - $3.08 Million	9,902 New	9,902 $2.71 Million
Q1 2021 May 12, 2021	SELL	$175.6 - $291.43 $1.76 Million - $2.92 Million	-10,004 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$174.98 - $272.83 $1.75 Million - $2.73 Million	10,004 New	10,004 $1.75 Million

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.